CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-03 | Lewis William Chair and CEO | Sale 10b5-1 | −6,768 | $78.44 | $531K | 379,534 |
| 2025-02-03 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2025-02-03 | Lewis William Chair and CEO | Sale 10b5-1 | −41 | $74.86 | $3K | 240,713 |
| 2025-02-03 | Lewis William Chair and CEO | Sale 10b5-1 | −745 | $76.43 | $57K | 239,968 |
| 2025-02-03 | Lewis William Chair and CEO | Sale 10b5-1 | −3,463 | $77.95 | $270K | 236,505 |
| 2025-02-03 | Lewis William Chair and CEO | Sale 10b5-1 | −2,581 | $78.40 | $202K | 233,924 |
| 2025-02-03 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −18,750 | 56,250 | ||
| 2025-02-03 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,830 | 211,800 | ||
| 2025-01-30 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion 10b5-1 | +50,000 | $16.16 | $808K | 147,083 |
| 2025-01-30 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion 10b5-1 | +41,140 | $13.67 | $562K | 188,223 |
| 2025-01-30 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −91,140 | $80.00 | $7.3M | 97,083 |
| 2025-01-30 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −50,000 | 0 | ||
| 2025-01-30 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −41,140 | 0 | ||
| 2025-01-15 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +18,750 | $22.76 | $427K | 411,339 |
| 2025-01-15 | Lewis William Chair and CEO | Sale 10b5-1 | −6,636 | $69.39 | $460K | 404,703 |
| 2025-01-15 | Lewis William Chair and CEO | Sale 10b5-1 | −22,696 | $70.32 | $1.6M | 382,007 |
| 2025-01-15 | Lewis William Chair and CEO | Sale 10b5-1 | −2,473 | $71.05 | $176K | 379,534 |
| 2025-01-15 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2025-01-15 | Lewis William Chair and CEO | Sale 10b5-1 | −1,499 | $69.40 | $104K | 239,255 |
| 2025-01-15 | Lewis William Chair and CEO | Sale 10b5-1 | −4,700 | $70.31 | $330K | 234,555 |
Page 31 of 42 · 826 trades